Company / Net Debt per Share
Arcus Biosciences, Inc. Net Debt per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
-$1.33
FY2025
5-year range
-$1.74 / -$1.33
FY2023-FY2025
Trend
+1.3%
vs FY2024
Sector context
#62 of 82
Health Care
What the data says
Arcus Biosciences, Inc.'s net debt per share of $-1.33 is lower than 76% of companies in the Health Care sector (FY2025). Increased from $-1.74 to $-1.33 over the past 2 years.
Based on SEC 10-K filings.
-1.33 in FY2025.
Increased from $-1.74 to $-1.33 over the past 2 years.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 24% in Health CareTop 24% of 82This company -$1.33 Sector average $13.70
▼
-109.7% below sector average
Key checks
Key Insights
- In FY2025, net debt per share increased 1.3% year-over-year.
- Ranks #62 out of 82 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -0.93 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.33 | +1.3% |
| FY2024 | -$1.35 | +22.5% |
| FY2023 | -$1.74 | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026